XML 79 R60.htm IDEA: XBRL DOCUMENT v3.24.0.1
Operating Expenses (Tables)
12 Months Ended
Dec. 31, 2023
Other Income and Expenses [Abstract]  
Schedule of General and Administrative Expenses and Other Expenses
Components of our general and administrative expenses, portfolio management costs, loan acquisition costs, and other expenses for the years ended December 31, 2023, 2022 and 2021 are presented in the following table.
Table 22.1 – Components of Operating Expenses
Years Ended December 31,
(In Thousands)202320222021
General and Administrative Expenses
Fixed compensation expense(1)
$53,525 $63,642 $46,328 
Annual variable compensation expense 14,75212,873 58,569 
Long-term incentive award expense (2)
24,85423,101 19,938 
Acquisition-related equity compensation expense (3)
— 3,813 
Systems and consulting12,454 14,193 14,445 
Office costs8,590 8,574 7,837 
Accounting and legal5,191 6,644 4,975 
Corporate costs3,628 3,675 3,388 
Other5,301 8,206 5,925 
Total General and Administrative Expenses128,295 140,908 165,218 
Portfolio Management Costs14,571 7,951 5,758 
Loan Acquisition Costs
Commissions3,746 7,154 7,116 
Underwriting costs1,633 3,368 7,645 
Transfer and holding costs1,787 1,244 1,458 
Total Loan Acquisition Costs7,166 11,766 16,219 
Other Expenses
Amortization of purchase-related intangible assets 12,430 13,969 15,304 
Other(4)
3,808 1,621 1,391 
Total Other Expenses16,238 15,590 16,695 
Total Operating Expenses$166,270 $176,215 $203,890 
(1)Includes $2 million and $7 million of severance and transition-related expenses for the years ended December 31, 2023 and 2022, respectively.
(2)For the years ended December 31, 2023, 2022 and 2021, long-term incentive award expense includes $18 million, $20 million and $14 million, respectively, of expense for awards settleable in shares of our common stock and $6 million, $3 million and $6 million, respectively, of expense for awards settleable in cash.
(3)Acquisition-related equity compensation expense relates to 588,260 shares of restricted stock that were issued to members of CoreVest management as a component of the consideration paid to them for our purchase of their interests in CoreVest in 2019.
(4)For the year ended December 31, 2023, Other includes a $6 million allocation of income to our servicing investment co-investors, net of a contra-expense for the reversal of a $2 million litigation reserve.